Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Morgia

Showing results (1-10 of 168) with videos related to

Pageof 17
Sort By:
European Urology|December 7, 2010
Does the use of silodosin to treat benign prostatic hyperplasia really offer something new?Giuseppe Morgia
Urologia|July 26, 2011
[The association of Serenoa repens, lycopene and selenium is superior to Serenoa repens alone in reducing benign prostatic hyperplasia]Francesco Squadrito, Giuseppe Morgia
International Journal of Urology : Official Journal of the Japanese Urological Association|September 9, 2015
Response to Editorial Comment from Dr Cantiello and Dr Damiano to Emerging links between non-neurogenic lower urinary tract symptoms secondary to benign prostatic obstruction, metabolic syndrome and its components: A systematic reviewGiorgio I Russo, Giuseppe Morgia
European Urology|February 28, 2009
CyberKnife in the treatment of prostate cancer: a revolutionary systemGiuseppe Morgia, Costantino De Renzis
Journal of Clinical Pathology|March 15, 2015
How to define cumulative cancer length for selecting candidate for active surveillance?Giorgio Ivan Russo, Giuseppe Morgia
European Urology|August 31, 2007
Dorsal onlay skin graft bulbar urethroplasty: long-term follow-upGuido Barbagli, Giuseppe Morgia, Massimo Lazzeri
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|June 2, 2015
Benign prostatic hyperplasia and metabolic syndrome: the expanding evidences of a new disease of aging maleGiorgio I Russo, Sebastiano Cimino, Giuseppe Morgia
Translational Andrology and Urology|November 19, 2020
Comment on: Safety and efficacy of mirabegron: analysis of a large integrated clinical trial database of patients with overactive bladder receiving mirabegron, antimuscarinics, or placeboCarmen Scandura, Giuseppe Morgia, Giorgio Ivan Russo
International Journal of Urology : Official Journal of the Japanese Urological Association|April 5, 2016
Re: Complex link between male lower urinary tract symptoms and metabolic syndrome: More than ethnic disparityDaniele Urzì, Giorgio I Russo, Giuseppe Morgia
Urologia|May 8, 2014
[5ARI and PSA: evidences]Giuseppe Morgia, Daniele Urzì, Giorgio Ivan Russo
Pageof 17

Showing results (1-10 of 168) with videos related to

Sort By:
Pageof 17
European Urology|December 7, 2010
Does the use of silodosin to treat benign prostatic hyperplasia really offer something new?Giuseppe Morgia
Urologia|July 26, 2011
[The association of Serenoa repens, lycopene and selenium is superior to Serenoa repens alone in reducing benign prostatic hyperplasia]Francesco Squadrito, Giuseppe Morgia
International Journal of Urology : Official Journal of the Japanese Urological Association|September 9, 2015
Response to Editorial Comment from Dr Cantiello and Dr Damiano to Emerging links between non-neurogenic lower urinary tract symptoms secondary to benign prostatic obstruction, metabolic syndrome and its components: A systematic reviewGiorgio I Russo, Giuseppe Morgia
European Urology|February 28, 2009
CyberKnife in the treatment of prostate cancer: a revolutionary systemGiuseppe Morgia, Costantino De Renzis
Journal of Clinical Pathology|March 15, 2015
How to define cumulative cancer length for selecting candidate for active surveillance?Giorgio Ivan Russo, Giuseppe Morgia
European Urology|August 31, 2007
Dorsal onlay skin graft bulbar urethroplasty: long-term follow-upGuido Barbagli, Giuseppe Morgia, Massimo Lazzeri
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|June 2, 2015
Benign prostatic hyperplasia and metabolic syndrome: the expanding evidences of a new disease of aging maleGiorgio I Russo, Sebastiano Cimino, Giuseppe Morgia
Translational Andrology and Urology|November 19, 2020
Comment on: Safety and efficacy of mirabegron: analysis of a large integrated clinical trial database of patients with overactive bladder receiving mirabegron, antimuscarinics, or placeboCarmen Scandura, Giuseppe Morgia, Giorgio Ivan Russo
International Journal of Urology : Official Journal of the Japanese Urological Association|April 5, 2016
Re: Complex link between male lower urinary tract symptoms and metabolic syndrome: More than ethnic disparityDaniele Urzì, Giorgio I Russo, Giuseppe Morgia
Urologia|May 8, 2014
[5ARI and PSA: evidences]Giuseppe Morgia, Daniele Urzì, Giorgio Ivan Russo
Pageof 17